C. Verhofstede, F. Van Wanzeele, B. Van Der Gucht, J. Pelgrom, L. Vandekerckhove, J. Plum, and D. Vogelaers. Journal of Medical Virology. 79:1254–1260 (2007).
Simply Managing Complex Data
Virology
S. Yerly , V. von Wyl , J. Böni , J. Schüpbach , P. Burgisser, T. Klimkait, M. Rickenbach, B. Ledergerber, H. Günthard, L. Perrin, and the Swiss HIV Cohort Study. Poster presented during the Forum for Collaborative HIV Research Standardization & Clinical Relevance of HIV Drug Resistance Working Group Meeting. Sitges, 2006.
NP Mze, C. Fernand-Laurent, S. Daugabel, O. Zanzouri, and SM Juillet. MDPI, Volume 15, Issue 2, doi:10.3390/genes15020259. (Click here to access the online article.)
TA Crowell, B. Danboise, A. Parikh, A. Esber, N. Dear, P. Coakley, A. Kasembeli, J. Maswai, S. Khamadi, E. Bahemana, M. Iroezindu, F. Kiweewa, J. Owuoth, J. Freeman, LL Jagodzinski, JA Malia, LA Eller, S. Tovanabutra, SA Peel, JA Ake, CS Polyak, AFRICOS Study Group. Clin Infect Dis, 2020 Aug 12; ciaa1161.doi: 10.1093/cid/ciaa1161.
C. Soulie, L. Assoumou, B. Abdi, S. Sayon, T. Nguyen, MA Valantin, L. Benigue, V. Ferre, C. Alloui, B. Montes, V. Avettand-Fenoel, C. Delaugerre, D. Descamps, E. Martinez, J. Reynes, G. Peytavin, D. Costagliola, C. Katlama, V. Calvez, and AG Marcelin on behalf of the ANRS-163 ETRAL study group. Journal of Antimicrobial Chemotherapy, 2020 Jul 1;75(7):1943-1949.doi: 10.1093/jac/dkaa090.
- Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy
- Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay
- First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
- Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification